Epstein Secrets

83.16M) reports that on Friday, a "senior counterterrorism official" told them "that Abu Muhammad al-Masri is probably dead." The AP (11/14, Lee, LaPorta) reports Al-Masri's death "is a blow to al-Qaida" and "comes amid rumors in the Middle East about the fate of the group's leader, Ayman al-Zawahiri.

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

83.16M) reports that on Friday, a "senior counterterrorism official" told them "that Abu Muhammad al-Masri is probably dead." The AP (11/14, Lee, LaPorta) reports Al-Masri's death "is a blow to al-Qaida" and "comes amid rumors in the Middle East about the fate of the group's leader, Ayman al-Zawahiri.

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying

83.16M) reports that on Friday, a "senior counterterrorism official" told them "that Abu Muhammad al-Masri is probably dead." The AP (11/14, Lee, LaPorta) reports Al-Masri's death "is a blow to al-Qaida" and "comes amid rumors in the Middle East about the fate of the group's leader, Ayman al-Zawahiri.

g maker to release an early analysis of vaccine trial data," could apply for the FDA's emergency authorization "as early as this week." BioNTech CEO Ugur Sahin: "If everything continues to go well, we will start to deliver the vaccine end of this year, beginning next year." However, Lopez added, "Supplying